Library Subscription: Guest
Begell Digital Portal Begell Digital Library eBooks Journals References & Proceedings Research Collections
International Journal of Medicinal Mushrooms
IF: 1.423 5-Year IF: 1.525 SJR: 0.431 SNIP: 0.661 CiteScore™: 1.38

ISSN Print: 1521-9437
ISSN Online: 1940-4344

International Journal of Medicinal Mushrooms

DOI: 10.1615/IntJMedMushrooms.2019030122
pages 267-273

Medicinal Sulphur Polypore Mushroom Laetiporus sulphureus (Agaricomycetes) Plus Tiny Amounts of Essential Oils Decrease the Activity of Crohn Disease

Bruno Donatini
Clinical Research, Medicine Information Formation, Cormontreuil, France
Isabelle Le Blaye
Clinical Research, Medicine Information Formation, Cormontreuil, France

ABSTRACT

A mixture of Laetiporus sulphureus (LS) and essential oils of Origanum vulgare, Cinnamomum verum, and Syzygium aromaticum (LOCS) was recommended for 24 patients with Crohn disease (CD). Patients were followed up for at least 24 months (median 32 months; range, 24-54 months). Nineteen patients were compliant with the treatment, although 3 stopped taking it, relapsed, began the LOCS regimen again, and recovered; 5 patients were not compliant at all. Compliant patients experienced flares of CD, with a CD Activity Index > 220, for 5.6% of the surveillance period (median 34 months). Noncompliant patients experienced flares of CD, with a CD Activity Index > 220, for 75.0% of the surveillance period (median 26 months; P < 10-6). Each case was then analyzed with a Bayesian approach that considered the probability of CD spontaneously disappearing within 2 weeks after intake of LOCS, the reappearance of CD within 2 weeks after stopping LOCS, and the disappearance of CD again after rechallenge. For the 19 compliant patients, the global posterior probability (probability that all the events observed were due to coincidence only) was equal to 10-6. Thus it can be concluded that LOCS decreases the CD Activity Index. Further investigations are necessary to unravel the mechanism of action of LOCS and to confirm its positive effect over periods as long as 5 to 10 years.


Articles with similar content:

Colorectal Cancer in Crohn's Disease—Review of a 56-Year Experience in Karolinska Institute University Hospital
Journal of Environmental Pathology, Toxicology and Oncology, Vol.27, 2008, issue 4
Carlos Rubio, Ragnar Befrits
Cost of Antibiotic Beads is Justified: A Study of Open Fracture Wounds and Chronic Osteomyelitis
Journal of Long-Term Effects of Medical Implants, Vol.17, 2007, issue 3
Brenton A. Wright, David Seligson, Craig S. Roberts, Arthur L. Malkani, Steven J. McCabe
The Experience on PDT by the Multidisciplinary Group in Padova
Forum on Immunopathological Diseases and Therapeutics, Vol.2, 2011, issue 3
Giorgio Battaglia, Lorenzo Norberto, Luigi Corti, Lamberto Toniolo
The Need for Animal Models in Small-Vessel Brain Disease
Critical Reviews™ in Neurobiology, Vol.18, 2006, issue 1-2
Rui Hua, Wolfgang Walz
A Histologic Analysis of a Retrieved Specimen 24 Years after Hemiresurfacing for Avascular Necrosis
Journal of Long-Term Effects of Medical Implants, Vol.29, 2019, issue 1
Matthew A. Harb, Aditya V. Maheshwari, Christopher Yiachos, Dipal Chatterjee, Henry M. Tischler, Stefan Tangl, Vincent J. Vigorita